Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001062993-14-004769
Filing Date
2014-08-13
Accepted
2014-08-12 20:34:54
Documents
9
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q form10q.htm 10-Q 266001
2 EXHIBIT 31.1 exhibit31-1.htm EX-31.1 4410
3 EXHIBIT 32.1 exhibit32-1.htm EX-32.1 3178
  Complete submission text file 0001062993-14-004769.txt   5056457

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE avxl-20140630.xml EX-101.INS 344556
5 XBRL SCHEMA FILE avxl-20140630.xsd EX-101.SCH 178086
6 XBRL CALCULATION FILE avxl-20140630_cal.xml EX-101.CAL 44319
7 XBRL DEFINITION FILE avxl-20140630_def.xml EX-101.DEF 489864
8 XBRL LABEL FILE avxl-20140630_lab.xml EX-101.LAB 1157691
9 XBRL PRESENTATION FILE avxl-20140630_pre.xml EX-101.PRE 538406
Mailing Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163
Business Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163 800-689-3939
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

EIN.: 208365999 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-51652 | Film No.: 141035546
SIC: 8731 Services-Commercial Physical & Biological Research